Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic RemissionTreat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Sponsor:

UCLA

Code:

NCT05230173

Conditions

Ulcerative Colitis

Crohn Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pragmatic

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of California, San Diego on 2024-04-15.